About TELIX PHARMACEUTICALS US INC
Telix Pharmaceuticals is a global, commercial-stage biopharmaceutical company focused on the development and commercialization of therapeutic and diagnostic radiopharmaceuticals, with a strong pipeline in urologic, neurologic, and musculoskeletal oncology. The company has received regulatory approvals in the U.S., Australia, and Canada for its prostate cancer imaging agent.
Recent Federal Awards
| Award | Agency | Amount | Date |
|---|---|---|---|
| RADIOPHARMACEUTICAL REQUEST, ILLUCCIX FOR PROSTATE CANCER IMAGING | Department of Veterans Affairs | $186K | |
| ILLUCCIX | Department of Veterans Affairs | $1.8M | |
| ILLUCCIX | Department of Veterans Affairs | $1.1M | |
| VARIOUS RADIOPHARMACEUTICALS OPT YR 1 | Department of Veterans Affairs | $848K | |
| ILLUCCIX FOR VASD NUCLEAR MED | Department of Veterans Affairs | $334K |
Is this your company?
Claim TELIX PHARMACEUTICALS US INC to unlock the federal & state contracts GovIntel's AI has matched to you right now — plus your own scored past-performance, who you're up against, and who's risky to team with.
Claim TELIX PHARMACEUTICALS US INC & see your matchesFree to claim. Takes about a minute.
Data compiled from public government sources including SAM.gov, USAspending.gov, and state procurement records. Last verified against federal award records. Inaccurate, or want this page removed? Request a correction or removal.